Literature DB >> 17341510

Pelvic-floor muscle function in women with pelvic organ prolapse.

Diane F Borello-France1, Victoria L Handa, Morton B Brown, Patricia Goode, Karl Kreder, Laura L Scheufele, Anne M Weber.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to determine whether pelvic organ prolapse severity, pelvic symptoms, quality of life, and sexual function differ based on pelvic-floor muscle function in women planning to have prolapse surgery. SUBJECTS AND METHODS: Three hundred seventeen women without urinary stress incontinence who were enrolled in a multicenter surgical trial were examined to determine pelvic-floor muscle function (by Brink scale score). The subjects were 61.6+/-10.2 (X+/-SD) years of age. Thirteen percent of the subjects had stage II (to the hymen) pelvic organ prolapse, 68% had stage III (beyond the hymen) prolapse, and 19% had stage IV (complete vaginal eversion) prolapse. Subjects with lowest (3-6) and highest (10-12) Brink scale scores were compared on prolapse severity, pelvic symptoms and bother, quality of life, and sexual function.
RESULTS: Subjects with the highest Brink scores (n=75) had less advanced prolapse, smaller genital hiatus measurements, and less urinary symptom burden compared with those with the lowest Brink scores (n=56). The results indicated that pelvic-floor muscle function was not associated with condition-specific quality of life or sexual function. DISCUSSION AND
CONCLUSION: Although modestly clinically significant, better pelvic-floor muscle function was associated with less severe prolapse and urinary symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17341510     DOI: 10.2522/ptj.20060160

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  9 in total

1.  Vaginal tactile imaging.

Authors:  Vladimir Egorov; Heather van Raalte; Armen P Sarvazyan
Journal:  IEEE Trans Biomed Eng       Date:  2010-05-17       Impact factor: 4.538

2.  Pelvic floor muscle function in the standing position in women with pelvic floor dysfunction.

Authors:  Sally Mastwyk; Jodie McClelland; Melinda Mary Cooper; Helena C Frawley
Journal:  Int Urogynecol J       Date:  2021-11-26       Impact factor: 1.932

3.  Pelvic muscle strength after childbirth.

Authors:  Sarah Friedman; Joan L Blomquist; Joann M Nugent; Kelly C McDermott; Alvaro Muñoz; Victoria L Handa
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

4.  Pelvic floor muscle function in women presenting with pelvic floor disorders.

Authors:  Michael D Moen; Michael B Noone; Brett J Vassallo; Denise M Elser
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-10

5.  The role of calpain-calpastatin system in the development of stress urinary incontinence.

Authors:  Yuzhong Wu; Li Zhang; Hangmei Jin; Jianhong Zhou; Zhenwei Xie
Journal:  Int Urogynecol J       Date:  2009-09-12       Impact factor: 2.894

Review 6.  Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis.

Authors:  Mahdyie Doaee; Maziar Moradi-Lakeh; Abbas Nourmohammadi; Seid Kazem Razavi-Ratki; Marzieh Nojomi
Journal:  Int Urogynecol J       Date:  2013-06-20       Impact factor: 2.894

7.  Effect of Pelvic Floor Workout on Pelvic Floor Muscle Function Recovery of Postpartum Women: Protocol for a Randomized Controlled Trial.

Authors:  Hongmei Zhu; Di Zhang; Lei Gao; Huixin Liu; Yonghui Di; Bing Xie; Wei Jiao; Xiuli Sun
Journal:  Int J Environ Res Public Health       Date:  2022-09-04       Impact factor: 4.614

8.  Pelvic floor muscle function in a general population of women with and without pelvic organ prolapse.

Authors:  Marijke Slieker-ten Hove; Annelies Pool-Goudzwaard; Marinus Eijkemans; Regine Steegers-Theunissen; Curt Burger; Mark Vierhout
Journal:  Int Urogynecol J       Date:  2010-03       Impact factor: 2.894

9.  Women's Experiences with Compliance with Pelvic Floor Home Exercise Therapy and Lifestyle Changes for Pelvic Organ Prolapse Symptoms: A Qualitative Study.

Authors:  María Torres-Lacomba; Beatriz Navarro-Brazález; María José Yuste-Sánchez; Beatriz Sánchez-Sánchez; Virginia Prieto-Gómez; Fernando Vergara-Pérez
Journal:  J Pers Med       Date:  2022-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.